Top Page
Bodycote
(LSE:BOY)
Bodycote (BOY) vs. iShares MSCI United Kingdom ETF (EWC)
Bodycote Business Overview & Revenue Model
Bodycote Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 757.10M | 802.50M | 743.60M | 615.80M | 598.00M |
| Gross Profit | 109.30M | 108.10M | 269.70M | 225.70M | 186.90M |
| EBITDA | 124.00M | 201.70M | 186.60M | 167.70M | 97.00M |
| Net Income | 20.00M | 85.60M | 73.70M | 59.50M | 400.00K |
Balance Sheet | |||||
| Total Assets | 1.07B | 1.14B | 1.17B | 1.07B | 1.11B |
| Cash, Cash Equivalents and Short-Term Investments | 19.10M | 45.20M | 37.20M | 39.30M | 30.70M |
| Total Debt | 150.90M | 96.90M | 136.60M | 156.20M | 128.80M |
| Total Liabilities | 397.50M | 344.40M | 385.70M | 384.40M | 428.60M |
| Stockholders Equity | 668.10M | 790.80M | 780.90M | 684.70M | 680.50M |
Cash Flow | |||||
| Free Cash Flow | 82.50M | 109.20M | 70.10M | 87.10M | 74.50M |
| Operating Cash Flow | 152.60M | 191.60M | 137.10M | 139.10M | 134.40M |
| Investing Cash Flow | -112.80M | -71.20M | -62.30M | -104.80M | -124.70M |
| Financing Cash Flow | -67.60M | -110.20M | -76.60M | -24.80M | -1.30M |
Bodycote Technical Analysis
Bodycote Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £5.70B | 24.74 | 23.79% | 1.39% | -0.32% | -3.96% | |
74 Outperform | £1.12B | 40.05 | 4.10% | 2.72% | -6.95% | -52.08% | |
73 Outperform | £573.03M | 20.76 | 8.04% | 4.36% | -7.30% | -59.71% | |
72 Outperform | £729.93M | 29.71 | 18.87% | 1.38% | 14.88% | 45.73% | |
71 Outperform | £5.34B | 32.87 | 14.19% | 2.29% | 0.10% | -15.33% | |
67 Neutral | £6.33B | 20.68 | 17.68% | 1.20% | -1.97% | 40.55% | |
65 Neutral | €10.66B | 24.01 | 6.13% | 2.50% | 4.78% | -14.92% |
Bodycote Corporate Events
Bodycote plc has announced a transaction involving the repurchase of its own shares as part of an extended share buyback programme. The company purchased 36,940 ordinary shares at a volume-weighted average price of 627.26 pence per share, with plans to cancel these shares, reducing the total number of shares in issue to 176,984,103. This move is part of a broader strategy to manage the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced an extension to its share buyback programme, increasing the total allocation to £120 million. This move, executed through Jefferies International Limited, aims to reduce the company’s share capital by repurchasing and cancelling shares, potentially impacting market perceptions and shareholder value.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote PLC has announced a significant change in its shareholder structure as FMR LLC, a Boston-based investment firm, has increased its voting rights in the company to 10.0027%. This acquisition of voting rights marks a substantial increase from the previous 5.78%, potentially impacting Bodycote’s corporate governance and strategic direction.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £980.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has completed the third tranche of its £30 million share buyback programme, purchasing 21,743 ordinary shares, which will be cancelled, leaving a total of 177,310,404 shares in issue. This move is part of a broader strategy to optimize capital structure and return value to shareholders, reflecting confidence in the company’s financial health and future prospects.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced the continuation of its share buyback program, purchasing 18,105 ordinary shares as part of an extended initiative. This move is part of a broader strategy to manage its capital structure and enhance shareholder value, having acquired a total of 14,072,256 shares since March 2024, reflecting the company’s commitment to returning value to its investors.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced the continuation of its share buyback program, purchasing 15,701 ordinary shares at an average price of 582.1958 pence per share. This move is part of an extended program that has seen the company buy back a total of 13,881,011 shares since March 2024, potentially signaling confidence in its financial health and aiming to enhance shareholder value.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced the continuation of its share buyback program, purchasing 27,288 ordinary shares at an average price of 562.7418 pence per share. This move is part of an extended program that has seen the company buy back a total of 13,38,123 ordinary shares since March 2024, reflecting its strategy to manage capital and enhance shareholder value.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced the continuation of its share buyback program, purchasing 31,337 ordinary shares at an average price of 565.1951 pence per share. This move is part of an extended program that began in December 2024, aiming to optimize the company’s capital structure and enhance shareholder value, with a total of 13,723,753 shares bought back since March 2024.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced the continuation of its share buyback programme, purchasing 38,679 of its own ordinary shares at an average price of 569.0436 pence per share. This move is part of an extended programme that has seen the company buy back a total of 13,692,416 shares since March 2024, which may impact the company’s market positioning by reducing the number of shares in circulation, potentially increasing shareholder value.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc announced the continuation of its share buyback program, purchasing 29,362 ordinary shares as part of its extended program. This move is part of a broader strategy to enhance shareholder value, having repurchased a total of 13,512,523 shares since March 2024, indicating a strong commitment to returning capital to shareholders and potentially improving market confidence.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote PLC has announced a change in its major holdings, with Martin Currie Investment Management Limited adjusting its voting rights in the company. The adjustment sees Martin Currie’s voting rights decrease from 5.27% to 4.96%, indicating a slight reduction in their stake. This change could potentially impact Bodycote’s shareholder dynamics and influence future decision-making processes within the company.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £890.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote’s recent trading update reveals a 6% decline in group revenue for the first four months of 2025 compared to the previous year, attributed to strong prior year comparators and reduced energy surcharges. Despite challenges in the Automotive and Industrial markets, the company has seen improvements in Civil Aerospace and Defence sectors. Bodycote is advancing its ‘Optimise, Perform & Grow’ strategy, aiming to enhance operational efficiency and resilience, with plans to expand its plant and overhead reduction program. The company anticipates a second-half weighted improvement in adjusted operating profit, driven by new contracts in Defence and Oil & Gas, as well as growth in Aerospace & Defence.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc announced that all resolutions proposed at its Annual General Meeting on May 21, 2025, were approved by shareholders. The resolutions included the re-election of board members, approval of the directors’ remuneration policy, and the renewal of authorities related to share capital management. The successful passage of these resolutions reflects shareholder confidence in the company’s governance and strategic direction, potentially strengthening Bodycote’s market position and operational stability.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced the appointment of Emmanuelle Dubu as a Non-Executive Director, effective June 23, 2025. Dubu, with extensive experience in international engineering and leadership roles, will join the Remuneration, Nomination, and Audit committees. Her background in metallurgy and international industry experience is expected to contribute significantly to Bodycote’s board. Additionally, Lili Chahbazi has been appointed as the Senior Independent Director, succeeding Patrick Larmon, who will step down from the board in September 2025. These changes reflect Bodycote’s strategic focus on strengthening its leadership team to enhance its market position and stakeholder engagement.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.
Bodycote plc has announced the continuation of its share buyback programme, purchasing 1,397 ordinary shares at an average price of 533.515 pence per share. This move is part of an extended programme that has seen the company buy back a total of 12,712,626 shares, aiming to cancel these shares and reduce the number of shares in circulation, which could potentially enhance shareholder value by increasing earnings per share.
The most recent analyst rating on (GB:BOY) stock is a Buy with a £955.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.